Insights: Education
The exchange of knowledge is a founding principle of Mayo Clinic. We provide a wide range of in-person, live online, and on-demand education opportunities. Our physicians and allied health staff are committed to sharing their knowledge with as many people as possible. Many of our offerings are accredited, and most are available without any additional fees.
To chat with a live representative, click the Live Chat button on the right of the screen.
“There are two objects of medical education: To heal the sick, and to advance the science.”
Charles H. Mayo, M.D.
Most recent posts
Join Mayo Clinic Laboratories and C2N Diagnostics for our webinar exploring how the evolution of blood biomarker testing for Alzheimer's disease has expanded access to earlier, less-invasive diagnosis. Focusing on the newly FDA-cleared PrecivityAD2 blood test, which is offered by Mayo Clinic Laboratories in collaboration with C2N Diagnostics, the discussion will highlight how results from blood biomarker testing can support timely diagnosis, informed clinical decision-making, and improved patient care.
This "Phlebotomy Webinar" will enhance the user’s knowledge regarding how the secrets of magicians can be used to reduce patient fear and anxiety associated with hospital and clinic visits. Attendees will be provided with research studies and rationale for using magic tricks and similar techniques to decrease exam length and possibly sedation needed during radiography exams. Visual examples of concepts will be demonstrated to ensure complete understanding. A variety of tools and recommendations will be offered to fit every health care worker’s comfort level. The goal of the presentation is to provide information that will improve the overall patient experience, as well as make the job of the care provider easier and more enjoyable.
In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).
This "Phlebotomy Webinar" presentation will review the methods available to detect latent infection with Mycobacterium tuberculosis, or latent tuberculosis infection (LTBI), including the classic tuberculin skin test and the more recently developed interferon gamma release assays (IGRA).
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses a recent change to the direct immunofluorescence assay, specifically the addition of the IgG4 conjugate.
The discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
This "Phlebotomy Webinar" presentation highlights the most common pre-analytical variables encountered in the hospital setting that may compromise blood specimen integrity and lead to specimen recollection.
Update your bookmark! Dangerous Goods can now be found at https://news.mayocliniclabs.com/dangerous-goods-training/
In this month’s “Hot Topic,” Andrew McKeon, M.B., B.Ch., M.D., reviews the use of neurological phenotype-based evaluations, the move away from the paraneoplastic evaluation, and upcoming changes to test profiles.
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the use of qualitative urine screening assays and quantitative confirmatory testing to determine compliance in pain management patients.
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted stimulant and PCP screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed CNS stimulant medications.
In this month’s Hot Topic, Robin Patel, M.D., discusses Mayo Clinic Laboratories’ new PCR assay for detection of Helicobacter pylori detection and determination of clarithromycin resistance directly from stool.